EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL
- 12 March 1988
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 331 (8585) , 545-549
- https://doi.org/10.1016/s0140-6736(88)91350-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: A placebo-controlled arteriographic coronary recanalization studyJournal of the American College of Cardiology, 1987
- INTRAVENOUS STREPTOKINASE GIVEN WITHIN 0-4 HOURS OF ONSET OF MYOCARDIAL INFARCTION REDUCED MORTALITY IN ISIS-2The Lancet, 1987
- Achievement of Coronary Artery Patency by Use of Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial InfarctionDrugs, 1987
- Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.BMJ, 1986
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsEuropean Heart Journal, 1985
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Effect of interventions in salvaging left ventricular function in acute myocardial infarction: A study of intracoronary streptokinaseThe American Journal of Cardiology, 1983
- Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1981